China will encourage low-price medicine production to reduce patients' medical bills, insiders told Economic Information Daily. They said a low-price medicine list is expected to be drawn up by the National Development and Reform Commission as the first step to reform medicine prices and that they will be protected by the government, which is expected to bring down the price of expensive medicines. This will have a huge impact on the country's pharmaceutical industry.